Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011
Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Central Nervous System Abnormalities in Lyme Neuroborreliosis
Neurol 41:1571-1582, Halperin,J.J.,et al, 1991
Narcolepsy Associated with Lesions of the Diencephalon
Neurol 39:1505-1508, Aldrich,M.S.&Naylor,M.W., 1989
Cellular Immunity In Guamanians with Amyotrophic Lateral Sclerosis & Parkinsonism-Dementia
NEJM 299:680-685, Hoffman,P.M.,et al, 1978
Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976
Cogan's Syndrome & HLA BW17
NEJM 295:1262, DelCarpio,J.,et al, 1976